DUBLIN--(BUSINESS WIRE)--The "Biosimilar Monoclonal Antibodies Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024" report has been added to ResearchAndMarkets.com's offering.
The study on biosimilar monoclonal antibodies market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific and RoW for the period of 2016 to 2024.
The report on biosimilar monoclonal antibodies market is a comprehensive
study and presentation of drivers, restraints, opportunities, demand
factors, market size, forecasts, and trends in the global biosimilar
monoclonal antibodies market over the period of 2016 to 2024.
Market Dynamics
Drivers
- Rising Demand for Biosimilar Drugs Owing to their Cost Effectiveness
- Prevalence of Chronic Diseases among Geriatric Population
Restraints
- Unfavorable Government Regulations in Developed Economies
- High Cost Associated With Manufacturing Process
Opportunities
- Growing Collaboration among the Local Players
Companies Profiled
- Pfizer Inc.
- Novartis AG
- Reliance Life Sciences
-
Allergan PLC
- Coherus BioSciences Inc.
- Biocon
- Boehringer Ingelheim GmbH
- BioXpress Therapeutics S.A.
- Intas Pharmaceuticals Limited
- Genor BioPharma Co. Ltd.
Key Topics Covered
1. Preface
2. Executive Summary
3. Global Biosimilar Monoclonal Antibodies Market Overview
4. Biosimilar Monoclonal Antibodies Market Macro Indicator Analysis
5. Global Biosimilar Monoclonal Antibodies Market by Application
6. Global Biosimilar Monoclonal Antibodies Market by Drug Class
7. Global Biosimilar Monoclonal Antibodies Market by Region
8. Company Profiles and Competitive Landscape
For more information about this report visit https://www.researchandmarkets.com/research/h6lvqt/global_biosimilar?w=4
